Enhanced clinician decision-making: structured data-sharing networks drive quality improvement

The FDA on Mon­day fi­nal­ized a long-await­ed rule that out­lines how it will reg­u­late lab­o­ra­to­ry-de­vel­oped tests (LDTs) as med­ical de­vices, even though some crit­ics say the

LENZ Ther­a­peu­tics is clear on the ben­e­fits of pre-com­mer­cial mar­ket­ing for its pres­by­opia eye drops, bol­stered by pos­i­tive Phase 3 news this week. The new